Latest Articles
February 6, 2017
Genetic Testing Accuracy Explained During the AmbrySpeaks-Los Angeles Event
Genetic Testing Accuracy Explained During the AmbrySpeaks-Los Angeles Event
Ambry Speaks Tour
AmbryShare
BRCA2
PALB2
Sanger Confirmation
February 2, 2017
Exome Sequencing Provides More Coverage Than You Think
New research suggests that whole exome sequencing (WES) offers similar base pair coverage to MGPT for Mendelian diseases.
Mendelian diseases
Multigene Panel Testing
Next Generation Sequencing
Novel Genes
University of California-Irvine
Whole Exome Sequencing
January 18, 2017
AmbrySpeaks’ Tour kicks off in Los Angeles
Ever since our initial publication of Sanger sequencing confirmation was featured in The Journal of Molecular Diagnostics, in addition to our accompanying presentation at the…
Ambry Speaks Tour
AmbryShare
Genetic Testing
Sanger Confirmation
December 23, 2016
New Research on Male Breast Cancer: Unexpected Results and Insights
Ambry Genetics, Huntsman Cancer Institute and Mayo Clinic conduct largest reported study of men with breast cancer undergoing multi-gene panel testing.
BRCA1 & 2
CHEK2
Huntsman Cancer Institute
Male Breast Cancer
Mayo Clinic
PALB2
December 18, 2016
Congratulations to the 2016 Battle for the Breasts Winners!
The Mauli Ola Foundation has announced the winning team of their 3rd annual Battle for the Breasts (B4TB) online surf contest, as of the end of October,…
Battle for the Breasts
BRCA1 & 2
Breast Cancer
Breast Cancer Awareness
Mauli Ola Foundation
December 14, 2016
Dr. Fergus Couch Talks with Ambry about Recent Study Findings
Mayo Clinic Researcher Dr. Fergus Couch talks with Ambry about recent findings from the largest hereditary breast cancer patient study to date.
ATM
BARD1
BRCA1 & 2
Breast Cancer
CHEK2
Mayo Clinic
RAD51D